Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Novel Protein Kinase Inhibitors Related to Tau Pathology Modulate Tau Protein-Self Interaction Using a Luciferase Complementation Assay.

Holzer M, Schade N, Opitz A, Hilbrich I, Stieler J, Vogel T, Neukel V, Oberstadt M, Totzke F, Schächtele C, Sippl W, Hilgeroth A.

Molecules. 2018 Sep 12;23(9). pii: E2335. doi: 10.3390/molecules23092335.

2.

Delayed Post-hypoxic Leukoencephalopathy (DPHL)-An Uncommon Variant of Hypoxic Brain Damage in Adults.

Beeskow AB, Oberstadt M, Saur D, Hoffmann KT, Lobsien D.

Front Neurol. 2018 Aug 27;9:708. doi: 10.3389/fneur.2018.00708. eCollection 2018.

3.
4.

TDP-43 self-interaction is modulated by redox-active compounds Auranofin, Chelerythrine and Riluzole.

Oberstadt M, Stieler J, Simpong DL, Römuß U, Urban N, Schaefer M, Arendt T, Holzer M.

Sci Rep. 2018 Feb 2;8(1):2248. doi: 10.1038/s41598-018-20565-0.

5.

Provision of assistive technology devices among people with ALS in Germany: a platform-case management approach.

Funke A, Spittel S, Grehl T, Grosskreutz J, Kettemann D, Petri S, Weyen U, Weydt P, Dorst J, Ludolph AC, Baum P, Oberstadt M, Jordan B, Hermann A, Wolf J, Boentert M, Walter B, Gajewski N, Maier A, Münch C, Meyer T.

Amyotroph Lateral Scler Frontotemporal Degener. 2018 Aug;19(5-6):342-350. doi: 10.1080/21678421.2018.1431786. Epub 2018 Jan 30.

PMID:
29382225
6.

TDP-43 and Cytoskeletal Proteins in ALS.

Oberstadt M, Claßen J, Arendt T, Holzer M.

Mol Neurobiol. 2018 Apr;55(4):3143-3151. doi: 10.1007/s12035-017-0543-1. Epub 2017 May 2. Review.

PMID:
28466273
7.

Late onset dHMN II caused by c.404C>G mutation in HSPB1 gene.

Oberstadt M, Mitter D, Classen J, Baum P.

J Peripher Nerv Syst. 2016 Jun;21(2):111-113. doi: 10.1111/jns.12165.

PMID:
26887567
8.

Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme.

Oberstadt MC, Bien-Möller S, Weitmann K, Herzog S, Hentschel K, Rimmbach C, Vogelgesang S, Balz E, Fink M, Michael H, Zeden JP, Bruckmüller H, Werk AN, Cascorbi I, Hoffmann W, Rosskopf D, Schroeder HW, Kroemer HK.

BMC Cancer. 2013 Dec 31;13:617. doi: 10.1186/1471-2407-13-617.

9.

MEF promotes stemness in the pathogenesis of gliomas.

Bazzoli E, Pulvirenti T, Oberstadt MC, Perna F, Wee B, Schultz N, Huse JT, Fomchenko EI, Voza F, Tabar V, Brennan CW, DeAngelis LM, Nimer SD, Holland EC, Squatrito M.

Cell Stem Cell. 2012 Dec 7;11(6):836-44. doi: 10.1016/j.stem.2012.09.012.

Supplemental Content

Loading ...
Support Center